Viability of Bacteriophages in the Complex Hydrogel Wound Dressings in vitro

Using bacteriophages to overcome the increasing resistance of microorganisms to antibiotics is a novel research venue of clinical importance. Among other challenges, this technique is expected to create and maintain an adequate local concentration of bacteriophages at the site of application. In addition, the possibility of combining the phage preparation with antioxidants and anesthetics may provide new options for stimulating the reparative process.

The aim of the study was to assess the viability and lytic activity of bacteriophages incorporated into a hydrogel-based wound dressing that contains polyvinyl alcohol, phosphate buffer, with optional additions of succinic acid and lidocaine.

Materials and Methods. A technique for incorporating bacteriophages into the complex hydrogel wound dressing ex tempore has been proposed. The bacteriolytic activity of phages inside the hydrogel was determined using standard microbiological techniques. Specifically, we used nutrient media with lawn cultures of Staphylococcus aureus added with the following antibacterial combinations: bacteriophages + succinic acid, bacteriophages + lidocaine, and bacteriophages + succinic acid + lidocaine. The lytic activity of bacteriophages was assessed within 1 to 7 days after the formation of the hydrogel.

Results. In all samples containing bacteriophages, the presence of viable and lytically active phages was noted within 1 to 7 days, as evidenced by the “negative colonies” on the culture lawns. On days 1 to 3, no secondary growth was recorded in the phage-containing samples. In hydrogel samples containing phages, succinic acid, and lidocaine, secondary bacterial colonies were detected starting from day 4 indicating some reduction in the lytic activity.

Conclusion. The results suggest that bacteriophages immobilized in the hydrogel maintain their viability and lytic activity, and this activity persists when the phages are combined with succinic acid and lidocaine.

1. Huber I., Potapova K., Kuhn A., Schmidt H., Hinrichs J., Rohde C., Beyer W. 1st German phage symposium — conference report. Viruses 2018; 10(4): 158, https://doi.org/10.3390/v10040158.
2. Pirnay J.P., Verbeken G., Ceyssens P.J., Huys I., De Vos D., Ameloot C., Fauconnier A. The magistral phage. Viruses 2018; 10(2): 64, https://doi.org/10.3390/v10020064.
3. Jault P., Leclerc T., Jennes S., Pirnay J.P., Que Y.A., Resch G., Rousseau A.F., Ravat F., Carsin H., Le Floch R., Schaal J.V., Soler C., Fevre C., Arnaud I., Bretaudeau L., Gabard J. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis 2019; 19(1): 35–45, https://doi.org/10.1016/S1473-3099(18)30482-1.
4. Galenko-Yaroshevskiy P.A., Mogilnaya G.M., Karas’ A.F. Influence of sodium succinate on histomorphological changes in autodermotransplant of rats. Byulleten eksperimental’noy biologii i meditsiny 1998; 126(11): 555–560.
5. Ávila-Salas F., Marican A., Pinochet S., Carreño G., Valdés O., Venegas B., Donoso W., Cabrera-Barjas G., Vijayakumar S., Durán-Lara E.F. Film dressings based on hydrogels: simultaneous and sustained-release of bioactive compounds with wound healing properties. Pharmaceutics 2019; 11(9): 447, https://doi.org/10.3390/pharmaceutics11090447.
6. Galenko-Yaroshevskiy P.A., Chekman I.S., Medvedev O.S. Dermatoprotective properties of sodium succinate in conditions of reduced blood circulation. Byulleten eksperimental’noy biologii i meditsiny 1998; 126(10): 420–424.
7. Zhao X., Sun Y., Li Z. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system. Drug Des Devel Ther 2018; 12: 4231–4240, https://doi.org/10.2147/dddt.s187177.
8. Yudanova T.N., Aleshina E.Yu., Galbraykh L.S., Krestianova I.N. Pharmacokinetic properties of films with combined biological action. Khimiko-farmatsevticheskii zhurnal 2003; 37(11): 26–28.
9. Ratsionalnoye primeneniye bakteriofagov v lechebnoy i protivoepidemicheskoy praktike. Federalnyye klinicheskiye rekomendatsii [Rational use of bacteriophages in medical and anti-epidemic practice. Federal clinical guidelines]. Moscow; 2014.
10. Nogueira F., Karumidze N., Kusradze I., Goderdzishvili M., Teixeira P., Gouveia I.C. Immobilization of bacteriophage in wound-dressing nanostructure. Nanomedicine 2017; 13(8): 2475–2484, https://doi.org/10.1016/j.nano.2017.08.008.
11. Bouhadir K.H., Alsberg E., Mooney D.J. Hydrogels for combination delivery of antineoplastic agents. Biomaterials 2001; 22(19): 2625–2633, https://doi.org/10.1016/s0142-9612(01)00003-5.
12. Kamoun E., Kenawy E.S., Chen X. A review on polymeric hydrogel membranes for wound dressing applications: PVA-based hydrogel dressings. J Adv Res 2017; 8(3): 217–233, https://doi.org/10.1016/j.jare.2017.01.005.
13. Caló E., Khutoryanskiy V.V. Biomedical applications of hydrogels: a review of patents and commercial products. Eur Polym J 2015; 65: 252–267, https://doi.org/10.1016/j.eurpolymj.2014.11.024.
14. Hoare T.R., Kohane D.S. Hydrogels in drug delivery: progress and challenges. Polymer 2008; 49(8): 1993–2007, https://doi.org/10.1016/j.polymer.2008.01.027.
15. Grijalvo S., Mayr J., Eritja R., Díaz D.D. Biodegradable liposome-encapsulated hydrogels for biomedical applications: a marriage of convenience. Biomater Sci 2016; 4(4): 555–574, https://doi.org/10.1039/c5bm00481k.
16. Boggione     D.M.G., Batalha    L.S., Gontijo    M.T.P., Lopez    M.E.S., Teixeira    A.V.N.C., Santos    I.J.B., Mendonça R.C.S. Evaluation of microencapsulation of the UFV-AREG1 bacteriophage in alginate-Ca microcapsules using microfluidic devices. Colloids Surf B Biointerfaces 2017; 158: 182–189, https://doi.org/10.1016/j.colsurfb.2017.06.045.
17. Ribeiro M.P., Espiga A., Silva D., Baptista P., Henriques J., Ferreira C., Silva J.C., Borges J.P., Pires E., Chaves P., Correia I.J. Development of a new chitosan hydrogel for wound dressing. Wound Repair Regen 2009; 17(6): 817–824, https://doi.org/10.1111/j.1524-475x.2009.00538.x.
18. Oliveira R.N., McGuinness G.B., Ramos M.E.T., Kajiyama C.E., Thiré R.M.S.M. Properties of PVA hydrogel wound-care dressings containing UK propolis. Macromol Symp 2016; 368(1): 122–127, https://doi.org/10.1002/masy.201500149.
19. Marican A., Avila-Salas F., Valdés O., Wehinger S., Villaseñor J., Fuentealba N., Arenas-Salinas M., Argandoña Y., Carrasco-Sánchez V., Durán-Lara E.F. Rational design, synthesis and evaluation of γ-CD-containing cross-linked polyvinyl alcohol hydrogel as a prednisone delivery platform. Pharmaceutics 2018; 10: 30, https://doi.org/10.3390/pharmaceutics10010030.
20. Valeyev V.V., Kovalenko A.L., Talikova E.V., Zaplutanov V.A., Delvig-Kamenskaya T.Yu. Biological functions of succinate (a review of foreign experimental studies). Antibiotiki i khimioterapiya 2015; 60(9–10): 33–37.

Beschastnov V.V., Ryabkov M.G., Leontiev A.E., Tulupov A.A., Yudanova T.N., Shirokova I.Yu., Belyanina N.А., Kovalishena O.V. Viability of Bacteriophages in the Complex Hydrogel Wound Dressings in vitro. Sovremennye tehnologii v medicine 2021; 13(2): 32, https://doi.org/10.17691/stm2021.13.2.03